Mark R. Hake

Mark R. Hake

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

When You Look at the Big Picture, Marathon Patent Group Stock Could Easily Double

Marathon Patent is significantly undervalued despite its meteoric rise. MARA stock is worth at least twice its present price based on a sum-of-the-parts analysis.

With FuelCell Stock Looking Extremely Overextended, Investors Should Sell

FuelCell stock looks extremely overextended and investors should sell. FCEL stock is not worth anywhere near its present price and analysts expect it to fall 50%.

Star Peak Energy Stock Will Double After SPAC Merger

Star Peak Energy's SPAC merger with Stem is set to double the price of STPK stock. Here's how the math works out.

Why EV Charger Nuvve Is Poised to Rise After the Merger

NBAC stock is worth 80.5% more at $34.50 per share once the SPAC reverse merger with EV charging company Nuvve is completed.

There’s Probably Not Much Left in the Tank for the Northern Genesis SPAC

Northern Genesis SPAC looks fully valued with its Lion Electric EV merger. NGA stock looks like it is fully valued, especially compared to other EV stocks.

Expect Xpeng Stock To Keep Moving Higher This Year As Sales Surge

Expect Xpeng stock to keep moving higher this year as sales surge. Xpeng stock is worth at least 64% more at $95 per share as its sales track Nio’s growth rate.

ElectraMeccanica Vehicles Capital Needs Will Keep Shares Range Bound For Now

ElectraMeccanica still needs capital. Until it can raise $150 million and start making retail sales, , SOLO stock looks overvalued.

Aurora Cannabis Has Raised Enough Capital To Warrant Your Attention

Aurora's capital raises will help the cannabis company to survive. ACB stock could stage a comeback this year if it uses the money to cut its crushing debt.

Why Fisker Continues to Look Significantly Undervalued

Fisker stock continues to look significantly undervalued. FSR stock is likely to double over the next two or three years, providing a 25% to 41% annual average return.

Zomedica May Be a Winner Once Its Pet Lab Product Launches

Zomedica looks like it will be a winner once its pet lab product launches. ZOM stock could be worth $2 or more if it can garner 10% of the pet diagnostic lab market share.